相关实验视频

Updated: May 9, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 3, 2011

一种DNA疫苗诱导SARS冠状病毒中和和小鼠的保护性免疫力

Zhi-Yong Yang¹, Wing-Pui Kong, Yue Huang

¹Vaccine Research Center, NIAID, National Institutes of Health, Building 40, Room 4502, MSC-3005, 40 Convent Drive, Bethesda, Maryland 20892-3005, USA.

|April 2, 2004

概括

开发一种针对SARS-CoV的DNA疫苗至关重要. 这项研究表明,DNA疫苗编码尖端糖蛋白诱导小鼠的保护性免疫力,突出其未来SARS疫苗的潜力.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

公共卫生措施制了SARS-CoV的爆发.
对于未来的SARS-CoV复发的担忧仍然存在.
一个SARS-CoV疫苗仍然是首要任务.

研究的目的:

为了评估编码SARS-CoV尖峰 (S) 糖蛋白的DNA疫苗.
评估疫苗在小鼠模型中诱导免疫反应和保护性免疫的能力.

主要方法:

用编码不同形式的S糖蛋白的表达载体进行DNA免疫.
对CD4和CD8T细胞反应的分析.
使用酶相关免疫吸收试验 (ELISA) 测量抗体标位.
评估中和抗体活性. 中和抗体活性.
在小鼠肺部病毒复制的量化.

主要成果:

DNA疫苗诱导了强大的T细胞 (CD4和CD8) 和抗体反应.
编码S糖蛋白产生的中和抗体的表达载体.
肺部的病毒复制减少了六个数量级以上.
保护是由幽默性免疫机制调节的,不依赖T细胞.

结论:

使用S糖蛋白DNA的基因疫苗接种引发了针对SARS-CoV的有效免疫反应.
这种方法在临床前动物模型中产生保护性免疫力.
进一步开发针对SARS-CoV的DNA疫苗是有必要的.

更多相关视频

Influenza A Virus Studies in a Mouse Model of Infection

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 8, 2017

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 6, 2021

相关概念视频

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...